TREA

97787004 - C CELLPOINT

Follow

Information

  • Trademark
  • 97787004
  • Serial Number
    97787004
  • Registration Number
    7498517
  • Filing Date
    February 08, 2023
    a year ago
  • Registration Date
    September 10, 2024
    4 months ago
  • Transaction Date
    September 10, 2024
    4 months ago
  • Status Date
    September 10, 2024
    4 months ago
  • Published for Opposition Date
    June 25, 2024
    7 months ago
  • Location Date
    September 09, 2024
    4 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    BERLIN, JUSTIN
  • Attorney Name
    Alexandra MacKay
  • Owners
Information
Mark Drawing Code
3
Mark Identification
C CELLPOINT
Case File Statements
  • GS0411: Education services, namely, organizing and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals; provision of training, namely, provision of training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug discovery, drug development and pharmaceuticals
  • DM0000: The mark consists of a red dot to the left of the letter "C" outlined in a blue and green background, to the left of the word "CELLPOINT" in stylized blue font.
  • GS0051: Pharmaceutical substances and preparations for human use, namely, pharmaceutical preparations and engineered patient T cells for the treatment of cancer; biopharmaceutical substances and preparations for human use, namely, biopharmaceutical preparations and engineered patient T cells for the treatment of cancer; clinical diagnostic reagents for medical use
  • PM0001: C CELL POINT
  • CC0000: The color(s) blue, red, and green is/are claimed as a feature of the mark.
  • GS0441: Medical services; medical and pharmaceutical advisory and consultancy services; preparing pharmaceuticals for others being engineered patient T-cells; medical services, namely, Stemcell and celltherapy services; Medical services relating to the removal, treatment and processing of human cells
  • GS0421: Medical, scientific and industrial research services in the field of pharmaceuticals, engineered patient T-cells, cell therapy, and gene therapy; pharmaceutical and biopharmaceutical research and development services; laboratory analysis and testing services in the field of gene expression, namely, analysis and testing of cells to determine the presence of particular genes; analysis and testing of cells to determine efficacy for treatment of cancer; development, examination, namely, quality control, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis and testing of medicaments; development of test systems in the nature of testing procedures and protocols, computer software for testing, reagents and testing kits for testing for pharmaceutical and biopharmaceutical products; development of databases in the medical, pharmaceutical and biopharmaceutical field and development of computer databanks containing information concerning gene expression and gene therapy; pharmaceutical drug development services; scientific research in the nature of conducting clinical trials for others; Providing information about the results of clinical trials for pharmaceutical products; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Case File Event Statements
  • 2/11/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/28/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/1/2023 - a year ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM
  • 8/21/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/25/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/25/2023 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/25/2023 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/17/2023 - a year ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/6/2023 - a year ago
    9 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/7/2024 - 11 months ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 2/7/2024 - 11 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/7/2024 - 11 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/9/2024 - 11 months ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/16/2024 - 11 months ago
    14 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 6/5/2024 - 7 months ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/25/2024 - 7 months ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/25/2024 - 7 months ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/10/2024 - 4 months ago
    18 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/10/2024 - 4 months ago
    19 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC